Navigation Links
Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
Date:12/3/2012

Boca Raton, FL (PRWEB) December 03, 2012

Healthcare Holdings Group, Inc. (HCH) is pleased to announce the addition of Mr. Robert A. Pearlman, current CEO of the Diabetes Research Institute Foundation (DRIF), to its Board of Directors.

Mr. Pearlman has long been aware of the company’s Personal Health Records (PHR) product--AccessMyRecords.com—and with their recent growth into the Electronic Health Records (EHR) market, Mr. Pearlman welcomed the opportunity to become an active Board member.

HCH’s Chairman and CEO, Mr. Lenny Tambasco, said “We are honored to have the insight and experience Mr. Pearlman brings to our entire team and corporate culture.” “I’m excited about their technological achievements and believe in the company’s commitment.” said Mr. Pearlman. “Their EHR suite of products can ultimately benefit many people who suffer chronic conditions, provide support to their families, and the physicians that treat them.” He went on to say “the Diabetes Research Institute Foundation’s cornerstone belief is that tomorrow is not soon enough to cure those living with diabetes….this company and their products answer the call to bring tomorrow’s medical technology into the hands of the people today.”

About Mr. Robert A. Pearlman
Mr. Pearlman became a Board Member of Healthcare Holdings Group, Inc. in 2012 and continues to serve as CEO of the Diabetes Research Institute Foundation. He joined DRIF in 1993 as Executive Vice President, and served in this role until 2003, when he was elected to his current position by the national board of directors. During his tenure, the organization has enjoyed exponential growth and revenues have increased more than twenty-fold. Working within the fundraising arena for more than 35 years, Mr. Pearlman is well-known and highly respected in business and philanthropic communities worldwide. He has served in high-level positions for various organizations in the U.S. and abr
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes
2. C8 MediSensors Gains CE Mark Approval for the C8 MediSensors Optical Glucose Monitor(TM) System for People with Diabetes
3. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
4. A molecule central to diabetes is uncovered
5. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
6. Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative
7. Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
8. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
9. Low testosterone levels could raise diabetes risk for men
10. New Findings of Daily Consumption of Soy Isoflavones and Cacao-Flavonoids in Diabetes Type 2 Patients
11. Gut Microbiota Transplantation may Prevent Development of Diabetes and Fatty Liver Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Genedata, a ... biotechnology, drug discovery, and life science research, today ... ™ as its bioinformatics platform for strain ... Genedata will provide AB Enzymes, one of the ... hosted solution of Genedata Selector accompanied by bioinformatics ...
(Date:5/22/2013)... 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced ... Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of Cleveland ... May 30 at 1:30 p.m. Eastern Time.  A live and ... the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... 2013 AudioNotch is ... tinnitus treatment. AudioNotch is pleased to announce a ... locations in both British Columbia and Alberta, Destination ... hearing services. AudioNotch's tinnitus treatment program is now ... a Destination Hearing clinic, patients have the detection ...
(Date:5/22/2013)... Mold remediation could take a toll on ... a way to cut down the process' expense. And so, ... the details of a method how to kill mold ... be prevented, My Cleaning Products said. But in case mold ... mold remediation must then be promptly implemented as it poses ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2
... the University of Helsinki, Finland, has succeeded in producing ... is reduced to a nano-scale (one nanometre being one ... undergo substantial changes. Unlike in bulk materials, in nanoparticles ... the number of atoms inside the material, which, among ...
... Corporation (Amex: ETC ) ("ETC" or ... will be exhibiting at the upcoming APWCA 2009 ... (APWCA) 2009 National Conference will be held April ... Philadelphia, Center City. The APWCA provides cutting-edge education ...
... Portfolio LAKE FOREST, Ill., March 16 ... equity firm focused exclusively on the healthcare ... CorePharma LLC ("CorePharma") has completed the acquisition ... Leucovorin Calcium tablets are the generic equivalent ...
Cached Biology Technology:Paper electrified by copper particles 2Environmental Tectonics Corporation Announces Participation at APWCA National Conference 2Environmental Tectonics Corporation Announces Participation at APWCA National Conference 3RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma 2
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
(Date:5/22/2013)... 22, 2013. Plastic additives known as phthalates (pronounced ... They turn up in flooring, plastic cups, beach ... Centers for Disease Control and Preventionthe bodies of ... come under increasing scrutiny. A growing collection of ... leech from packaging and mix with food) may ...
(Date:5/21/2013)... Biologists have known for a long time that some ... well understood, particularly for plants. But it may be ... Australian National University and the U. S. National Evolutionary ... published 21 May in the journal Nature Communications ... faster-changing genomes. , Drawing from a database of global ...
Breaking Biology News(10 mins):Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Small but speedy: Short plants live in the evolutionary fast lane 2
... have identified a subtype of ovarian cancer able to build ... especially susceptible to "anti-angiogenic" drugs that block blood vessel formation. ... PloS ONE , the investigators estimate that the subtype may ... common cancer of the surface of the ovaries. The ...
... AUSTIN, Texas Chemists at The University of Texas at ... inside the double helix of a DNA sequence that it can ... itself, much longer than any other molecule reported. It,s an ... go after rogue DNA directly. Such drugs would be revolutionary in ...
... , The Springer journal Analytical and Bioanalytical Chemistry ... as the recipients of its Best Paper Award 2011. Rmpp ... in ABC on mass spectrometry imaging. The award, accompanied by ... scientists and to stimulate their research careers. The ABC Best ...
Cached Biology News:New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs 2New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs 3New molecule can tangle up DNA for more than 2 weeks 2ABC Best Paper Award 2011 goes to Andreas Römpp and Sabine Guenther 2
...
Vitellogenin (Japanese medaka) Standard...
... SAGE (serial analysis of ... genome-wide expression analysis. Expression profiles ... enough to detect low-abundance transcripts ... novel genes. The I-SAGE Kit ...
...
Biology Products: